Stay updated on recent management changes in various companies, including Meta Platforms, Southwest Airlines, and Ulta Beauty.
on Monday announced the appointment of Norman Staskey as its Chief Financial Officer (CFO). Staskey joins from Danforth Advisors, where he has served since 2021, providing CFO services to clients ...
SAN DIEGO - Organovo Holdings, Inc. (NASDAQ:ONVO), a biotechnology firm engaged in the development of treatments for inflammatory bowel disease and other conditions, announced the appointment of ...
today announced that it had appointed Norman Staskey as Chief Financial Officer. Mr. Staskey has worked for Danforth Advisors since 2021, working as Chief Financial Officer for clients such as Azitra, ...
Organovo Holdings, Inc., a clinical stage biotechnology company focused on treating inflammatory bowel disease (IBD), has appointed Norman Staskey as the new Chief Financial Officer. Staskey ...
today announced that it had appointed Norman Staskey as Chief Financial Officer. Mr. Staskey has worked for Danforth Advisors since 2021, working as Chief Financial Officer for clients such as ...